All News
ACIP Recommendations for Pfizer Vaccine Candidate
The CDC advisory panel, ACIP, has voted and declared that the first wave of vaccines should go to the front line healthcare workers and elderly residents in long term care facilities as part of Phase1a. The decision was not unanimous.
Read Article
RheumNow Podcast – Back Talk Listener Questions (12.04.20)
Dr Jack Cush takes questions from RheumNow listeners
Read Article
Tight Control Tune: Third Verse, Same as the First? TICOSPA. Dr. Jeff Curtis ( @RADoctor) reviews abstract #1444 at #ACR20.
https://t.co/4tqWuzwn54 https://t.co/u0vn4d1yF8
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @drdavidliew :The 'triple M' irAEs (myositis/myocarditis/MG): one of the rheumatic irAEs where autoAb are freq pos
Nice systematic review:
any autoAb+ 61% tested
MG+ 59% tested
MSA+ in 27% tested (18/67, 11 had myositis alone) https://t.co/aQHapPbjw9
Dr. John Cush RheumNow ( View Tweet)
Check out our latest.
PIANO Study - Safety of Biologics in Pregnancy
https://t.co/XskLByJZ9n https://t.co/JBHKo0T0jX
Links:
Dr. John Cush RheumNow ( View Tweet)
New podcast!
Dr Jack Cush takes questions from RheumNow listeners
PIANO Study - Safety of Biologics in Pregnancy
Premature osteoporosis and high tryptase
Mega-methotrexate doses
SLE criteria and SLEDAI substitutions
https://t.co/45n3KjJHqs
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @uptoTate : Study out of China, #ABS1892 shows that patient reported outcomes using self assessments are important in AS T2T and decreasing flare rates #ACR20 @RheumNow. https://t.co/vWjvAEeDMi https://t.co/HdMKSkkJ8I
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @RichardPAConway : Dr Kaellmark reports on immunogenicity of adjuvant herpes zoster subunit vaccine in RA patients treated with JAKi. 40 RA patients and 20 controls. Satisfactory serological responses and tolerability seen. @rheumnow #ACR20 Abstr#1997 https://t.co/TR9IS9hUgu
Dr. John Cush RheumNow ( View Tweet)
Missing the Mark: AxSpa Treat to Target (TICOSPA Trial): Dr. Lianne Gensler #ACR20
https://t.co/ePrhQ90kwD
Links:
Dr. John Cush RheumNow ( View Tweet)
Check out our latest article from Richard Conway ( @RichardPAConway) #ACR20
The tantalising prospect of glucocorticoid-free treatments for systemic vasculitis
https://t.co/VG1ah3Nq5c https://t.co/js3l527VHg
Links:
Dr. John Cush RheumNow ( View Tweet)
Revisit #ACR20 through the RheumNow podcast. Day 2, Part III available now.
https://t.co/rgvlZzVMkX
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @MeralElRamahiMD : A large observat study showed no difference in risk of major CV events in RA pts that were newly started on either MTX or HCQ. A greater stroke risk but lower risk of MI; hospitalized HF was seen in MTX initiators. #Abst1993 #ACR20
Dr. John Cush RheumNow ( View Tweet)
Check out the latest from Dr. Bella Mehta ( @bella_mehta) #ACR20
Racial disparities in Bilateral Knee Arthroplasty in Osteoarthritis
https://t.co/yataL7H8X4 https://t.co/xT1vCBDLyZ
Links:
Dr. John Cush RheumNow ( View Tweet)
Revisit #ACR20 through the RheumNow podcast. Day 2, Part II available now.
https://t.co/NipWyiTqtl https://t.co/kBz2jVaSLN
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
"RT @drdavidliew : Just a reminder:
inflammatory arthritis irAEs can occur at almost any time after immune checkpoint inhibitor cancer immunotherapy is commenced.
@LoyolaChicago #ACR20 ABST1566 @RheumNow https://t.co/x7DLzZcn9o https://t.co/OmpTAorA13
Links:
Dr. John Cush RheumNow ( View Tweet)
Dr. Ruderman ( @JointMD) discusses a new pathway - the use of deucravacitinib - to treat psoriatic arthritis at #ACR20.
https://t.co/1uz47jKVPv https://t.co/1I5B14w9Ox
Links:
Dr. John Cush RheumNow ( View Tweet)
Imaging and Large Vessel Vasculitis: Dr. Alexa S. Meara interviews Dr. Kaitlin Quinn #ACR20
https://t.co/CWN2C1P6Fz https://t.co/yHg63VPkiW
Links:
Dr. John Cush RheumNow ( View Tweet)
Pregnancy in SpA Patients: Dr Rachel Tate ( @uptoTate) #ACR20
https://t.co/GPrwd9HU5W https://t.co/TbwN4dZNul
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @MeralElRamahiMD : Wonder if you can predict which pts you can taper off bDMARDs? Abst#1538 from Denmark showed that a neg IgM-RF (OR 0.26); low Doppler serum score for 24 jts predicted discontinuation of bDMARDs at 2yr f/u in RA pts w/ DAS28-CRP<2.6. https://t.co/6hv5M1CQwT
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @bella_mehta :Anakinra in #Stills disease - Dbl blind, placebo controlled RCT in Stills disease total 12pts, 6 placebo, 6 Rx grp. All pts reached ACR70 at wk 2 without fever and sustained it at 12 weeks. 5/6 reached ACR90
ABS#1633 https://t.co/CCL6GONnvX https://t.co/KaoXBj3Azp
Links:
Dr. John Cush RheumNow ( View Tweet)